Clearance Summary
Tango Neo, Tango Reflex Neo, Ultra Q Reflex Neo received FDA 510(k) clearance under submission number K222395, sponsored by Ellex Medical Pty, Ltd.. The device was reviewed via the Traditional premarket notification pathway and assigned to the Ophthalmic review panel. The statutory decision date of record is 2022-11-02.
- Submission: K222395
- Applicant / Sponsor: Ellex Medical Pty, Ltd.
- Clearance pathway: Traditional
- Review panel: Ophthalmic
- Device class: Class II
- Regulation citation: 21 CFR 886.4390
- Decision date: 2022-11-02
Classification & Regulation
This clearance is catalogued under FDA product code HQF and 21 CFR 886.4390, within the Ophthalmic review panel as a Class II device.